West Pharmaceutical Services | WST - Gross Profit On Sales

Stock Price
248.95
Daily Change
17.33 7.48%
Monthly
-10.59%
Yearly
-22.58%
Q1 Forecast
224.00

West Pharmaceutical Services reported $294.3M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Align Technology USD 683.59M 44.39M Dec/2025
Avanos Medical USD 86M 6.1M Sep/2025
Baxter International USD 950M 194M Sep/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
Dentsply International USD 441M 49M Sep/2025
Haemonetics USD 202.39M 7.64M Dec/2025
ICU Medical USD 200.88M 7.18M Sep/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
J&J USD 16.6B 118M Dec/2025
Medtronic USD 5.44B 123M Sep/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Neogen USD 94.97M 2.11M Jun/2025
Quidel USD -733M 1.01B Sep/2025
Repligen USD 100.52M 9.37M Sep/2025
Solventum Corp USD 1.14B 40M Sep/2025
STAAR Surgical USD 77.88M 45.08M Sep/2025
Terumo JPY 147B 1.53B Sep/2025
West Pharmaceutical Services USD 294.3M 20.4M Sep/2025